We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Somalogic Webinar

Identifying Biomarkers for IBD Diagnosis and Management

Driving biomarker discovery is key as proteomics emerges as the next frontier in precision medicine.

In this webinar, you’ll hear how proteomics technology can enhance the identification of biomarkers for the accurate diagnosis of Crohn’s disease and ulcerative colitis, as well as the identification of biomarkers that predict response to TNF inhibitors and other biologics in patients with IBD. 

This webinar will explore how reliable, non-invasive proteomic biomarkers are pivotal for personalized treatment and increasing our knowledge of biological pathways involved in disease. Our expert speaker will also present an assay platform that can measure 11,000 biologically relevant proteins in the search for biomarkers.

Attend this webinar to:
  • Explore the role of biomarkers in tailoring medical care and enhancing precision in pediatric IBD treatment
  • Uncover serum proteins intricately linked to TNF inhibitor response, gaining insights for improved therapeutic decision-making in IBD
  • Discover how the SomaScan® 11K Assay transforms non-invasive biomarker discovery, revolutionizing differential pediatric IBD diagnosis.
Dr. Towia A. Libermann
Dr. Towia A. Libermann
Associate Professor of Medicine, Beth Israel Deaconess Medical Center
Harvard Medical School

Interested in sponsoring this webinar? Contact our friendly sales team here.
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Want to invite a colleague?

Click the button below to begin inviting a colleague to this Webinar